Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study

BACKGROUND: Antiviral therapy cannot completely block the progression of hepatitis B to hepatocellular carcinoma (HCC). Furthermore, there are few predictors of early HCC progression and limited strategies to prevent progression in patients with HBV-related cirrhosis who receive nucleos(t)ide analog...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Dan-Hong, Wang, Wei-Ping, Zhang, Qiang, Pan, Hong-Ying, Huang, Yi-Cheng, Zhang, Jia-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108039/
https://www.ncbi.nlm.nih.gov/pubmed/34007137
http://dx.doi.org/10.3748/wjg.v27.i17.2025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108039/
https://www.ncbi.nlm.nih.gov/pubmed/34007137
http://dx.doi.org/10.3748/wjg.v27.i17.2025

Ejemplares similares